Inventor
MCCHESNEY JAMES D
US53 patents
⚠️ This page may combine multiple inventors who share the name “MCCHESNEY JAMES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TAPESTRY PHARMACEUTICALS INC
19 patentsUS7745650B2Jun 29, 2010
9,10-α,α-OH-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC28 citations95
US7879904B2Feb 1, 2011
9, 10-α,α-OH-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC21 citations92
US7153946B2Dec 26, 2006
Molecular conjugates for use in treatment of cancer
TAPESTRY PHARMACEUTICALS INC33 citations90
US6825166B2Nov 30, 2004
Molecular conjugates for use in treatment of cancer
TAPESTRY PHARMACEUTICALS INC15 citations81
US11147793B2Oct 19, 2021
Taxane analogs for the treatment of brain cancer
TAPESTRY PHARMACEUTICALS INC1 citations71
US11786504B2Oct 17, 2023
Taxane analogs for the treatment of brain cancer
TAPESTRY PHARMACEUTICALS INC0 citations61
US12583865B2Mar 24, 2026
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations60
US11873308B2Jan 16, 2024
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations60
US11220512B2Jan 11, 2022
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations60
US10639293B2May 5, 2020
9,10-α,α-OH-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC0 citations51
US10238621B2Mar 26, 2019
9,10-α,α-OH-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC0 citations51
US10143677B2Dec 4, 2018
Taxane analogs for the treatment of brain cancer
TAPESTRY PHARMACEUTICALS INC0 citations51
US9820962B2Nov 21, 2017
9, 10-α, α-oh-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC0 citations51
US9402824B2Aug 2, 2016
9,10-α, α-OH-taxane analogs and methods for production thereof
TAPESTRY PHARMACEUTICALS INC0 citations51
US10745408B2Aug 18, 2020
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations50
US10450323B2Oct 22, 2019
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations50
US9802951B2Oct 31, 2017
Biologically active taxane analogs and methods of treatment by oral administration
TAPESTRY PHARMACEUTICALS INC0 citations50
US9616043B2Apr 11, 2017
Taxane analogs for the treatment of brain cancer
TAPESTRY PHARMACEUTICALS INC0 citations50
US9132118B2Sep 15, 2015
Taxane analogs for the treatment of brain cancer
TAPESTRY PHARMACEUTICALS INC0 citations50
NAPRO BIOTHERAPEUTICS INC
11 patentsUS6281368B1Aug 28, 2001
Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
NAPRO BIOTHERAPEUTICS INC25 citations91
US6358996B1Mar 19, 2002
Stable isotope labeling of paclitaxel
NAPRO BIOTHERAPEUTICS INC24 citations88
US6495705B2Dec 17, 2002
Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
NAPRO BIOTHERAPEUTICS INC14 citations84
US6143902ANov 7, 2000
C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof
NAPRO BIOTHERAPEUTICS INC6 citations73
US6136999AOct 24, 2000
C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof
NAPRO BIOTHERAPEUTICS INC7 citations73
US6066749AMay 23, 2000
Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis
NAPRO BIOTHERAPEUTICS INC13 citations72
US6048990AApr 11, 2000
Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
NAPRO BIOTHERAPEUTICS INC14 citations72
US5914411AJun 22, 1999
Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position
NAPRO BIOTHERAPEUTICS INC10 citations72
US6479679B1Nov 12, 2002
Two-step conversion of protected taxane ester to paclitaxel
NAPRO BIOTHERAPEUTICS INC2 citations62
US6448417B1Sep 10, 2002
Methods and useful intermediates for paclitaxel synthesis from C-7, C-10 di-cbz 10-deacetylbaccatin III
NAPRO BIOTHERAPEUTICS INC3 citations61
US6452025B1Sep 17, 2002
Three-step conversion of protected taxane ester to paclitaxel
NAPRO BIOTHERAPEUTICS INC1 citations52
MCCHESNEY JAMES D
10 patentsUS5225562AJul 6, 1993
Method of preparing (+)-deoxoartemisinin and selected analogues of (+)-deoxoartemisinin
MCCHESNEY JAMES D28 citations91
US8440714B2May 14, 2013
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
MCCHESNEY JAMES D7 citations81
US4920147AApr 24, 1990
Deoxoartemisinin: new compound and composition for the treatment of malaria
MCCHESNEY JAMES D8 citations72
US8273789B2Sep 25, 2012
Biologically active taxane analogs and methods of treatment by oral administration
MCCHESNEY JAMES D3 citations71
US5023353AJun 11, 1991
Deoxoartemisinin: new compound and composition for the treatment of malaria
MCCHESNEY JAMES D3 citations61
US8801924B2Aug 12, 2014
Chromatography methods
MCCHESNEY JAMES D2 citations60
US8552056B2Oct 8, 2013
Biologically active taxane analogs and methods of treatment by oral administration
MCCHESNEY JAMES D1 citations58
US9227983B2Jan 5, 2016
Taxane and abeo-taxane analogs
MCCHESNEY JAMES D0 citations48
US8912229B2Dec 16, 2014
Taxane and abeo-taxane analogs
MCCHESNEY JAMES D0 citations48
US8409574B2Apr 2, 2013
Taxane analogs for the treatment of brain cancer
MCCHESNEY JAMES D0 citations48
ARBOR THERAPEUTICS LLC
6 patentsUS10172957B2Jan 8, 2019
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
ARBOR THERAPEUTICS LLC1 citations69
US8716328B2May 6, 2014
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
ARBOR THERAPEUTICS LLC1 citations59
US9468603B2Oct 18, 2016
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
ARBOR THERAPEUTICS LLC1 citations57
US9889201B2Feb 13, 2018
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
ARBOR THERAPEUTICS LLC0 citations48
US9339555B2May 17, 2016
Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
ARBOR THERAPEUTICS LLC0 citations48
US10064823B2Sep 4, 2018
Nanoparticulate compositions for targeted delivery of acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation
ARBOR THERAPEUTICS LLC0 citations46
UNIV MISSISSIPPI
2 patentsZYGMUNT JAN
1 patentIRONSTONE SEPARATIONS INC
1 patentShowing the top 50 of 53 patents by PatentIndex Score.